Constitutive expression of arginase in microvascular endothelial cells counteracts nitric oxide‐mediated vasodilatory function

This publication has 30 references indexed in Scilit:

• The Involvement of Tyrosine Kinases, Cyclic AMP/Protein Kinase A, and p38 Mitogen-Activated Protein Kinase in IL-13-Mediated Arginase I Induction in Macrophages: Its Implications in IL-13-Inhibited Nitric Oxide Production
  The Journal of Immunology, 2000
• IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells
  American Journal of Physiology-Cell Physiology, 2000
• Arginase modulates nitric oxide production in activated macrophages
  American Journal of Physiology-Heart and Circulatory Physiology, 1998
• Human type II arginase: sequence analysis and tissue-specific expression
  Gene, 1997
• Comparative properties of arginases
  Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 1996
• Acidosis-Induced Coronary Arteriolar Dilation Is Mediated by ATP-Sensitive Potassium Channels in Vascular Smooth Muscle
  Circulation Research, 1996
• Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions.
  Hypertension, 1994
• L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation
  Biochemical and Biophysical Research Communications, 1988
• Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
  Proceedings of the National Academy of Sciences, 1987
• Molecular cloning and nucleotide sequence of cDNA for human liver arginase.
  Proceedings of the National Academy of Sciences, 1987